These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26130439)

  • 1. Human telomerase inhibitors from microbial source.
    Kiran KG; Palaniswamy M; Angayarkanni J
    World J Microbiol Biotechnol; 2015 Sep; 31(9):1329-41. PubMed ID: 26130439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting telomeres and telomerase.
    De Cian A; Lacroix L; Douarre C; Temime-Smaali N; Trentesaux C; Riou JF; Mergny JL
    Biochimie; 2008 Jan; 90(1):131-55. PubMed ID: 17822826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibitors: a patent review (2010-2015).
    Man RJ; Chen LW; Zhu HL
    Expert Opin Ther Pat; 2016 Jun; 26(6):679-88. PubMed ID: 27104627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomerase: an unusual target for cytotoxic agents.
    Corey DR
    Chem Res Toxicol; 2000 Oct; 13(10):957-60. PubMed ID: 11080041
    [No Abstract]   [Full Text] [Related]  

  • 5. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Telomere and telomerase in human cancer].
    Hiyama K; Hiyama E; Ishioka S; Yamakido M
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):196-201. PubMed ID: 9030230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomeres and telomerase as targets for anticancer drug development.
    Olaussen KA; Dubrana K; Domont J; Spano JP; Sabatier L; Soria JC
    Crit Rev Oncol Hematol; 2006 Mar; 57(3):191-214. PubMed ID: 16469501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and pharmacological regulation of telomerase.
    Mergny JL; Riou JF; Mailliet P; Teulade-Fichou MP; Gilson E
    Nucleic Acids Res; 2002 Feb; 30(4):839-65. PubMed ID: 11842096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibitors: a new option for chemotherapy.
    Chen Z; Corey DR
    Adv Cancer Res; 2003; 87():31-58. PubMed ID: 12641273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as an emerging target to fight cancer--opportunities and challenges for nanomedicine.
    Philippi C; Loretz B; Schaefer UF; Lehr CM
    J Control Release; 2010 Sep; 146(2):228-40. PubMed ID: 20381558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
    Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
    Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human telomerase inhibition by regioisomeric disubstituted amidoanthracene-9,10-diones.
    Perry PJ; Reszka AP; Wood AA; Read MA; Gowan SM; Dosanjh HS; Trent JO; Jenkins TC; Kelland LR; Neidle S
    J Med Chem; 1998 Nov; 41(24):4873-84. PubMed ID: 9822556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase inhibitors.
    Rowley PT; Tabler M
    Anticancer Res; 2000; 20(6B):4419-29. PubMed ID: 11205282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of new benzimidazole-carbazole conjugates for the stabilization of human telomeric DNA, telomerase inhibition, and their selective action on cancer cells.
    Maji B; Kumar K; Kaulage M; Muniyappa K; Bhattacharya S
    J Med Chem; 2014 Aug; 57(16):6973-88. PubMed ID: 25062468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer targeting telomerase inhibitors: β-rubromycin and oleic acid.
    Mizushina Y; Takeuchi T; Sugawara F; Yoshida H
    Mini Rev Med Chem; 2012 Oct; 12(11):1135-43. PubMed ID: 22876944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase-based therapies emerging slowly.
    Brower V
    J Natl Cancer Inst; 2010 Apr; 102(8):520-1. PubMed ID: 20388877
    [No Abstract]   [Full Text] [Related]  

  • 18. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
    Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
    Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Modeling and Evaluation of Novel Dibenzopyrrole Derivatives as Telomerase Inhibitors and Potential Drug for Cancer Therapy.
    Kalathiya U; Padariya M; Baginski M
    IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(6):1196-207. PubMed ID: 26357055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.